EIF2AK2 and breast cancer: To determine the role of PKR on breast cancer cell response to chemotherapy agents, MCF7, T-47D and MDA-MB-231 cells expressing either siRNA to PKR or control siRNA were treated with doxorubicin (DOX) and viability was measured by Trypan blue dye exclusion assay.